Results 211 to 220 of about 270,393 (395)
Eosinophilic Infiltrations of the Lungs in Asthmatics [PDF]
J. G. Scadding
openalex +1 more source
Recurrent fexuprazan‐induced liver injury following unintentional re‐exposure
Fexuprazan, a potassium‐competitive acid blocker, is increasingly used for the treatment of gastroesophageal reflux disease in South Korea. While generally well tolerated, data regarding its hepatotoxic potential are scarce. We report a case of idiosyncratic drug‐induced liver injury in a 61‐year‐old woman following 2 months of fexuprazan therapy.
Sook Jin Seong+5 more
wiley +1 more source
THE ESTIMATION OF THE PROPORTION OF MOTILE BULL SPERMATOZOA IN VARIOUS DILUENTS AND A COMPARISON WITH THE PROPORTION EOSINOPHILIC [PDF]
H. M. Dott
openalex +1 more source
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma
Aims Inhaled corticosteroids (ICS) plus bronchodilator are recommended for the treatment of asthma. Targeting the JAK1‐dependent pathway may be an alternative for asthma management in patients with incomplete response to ICS. The aim of this study was to investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of AZD0449, a
Anna Lundahl+11 more
wiley +1 more source
Fusion Pores as Regulators of Quantal Size and Cellular Physiology
During regulated exocytosis, membrane fusion regulatory factors act directly on SNAREs and membrane lipids to control fusion pore dynamics. This, in turn, leads to a differential amount of cargo release (referred to in this article as “quantal size”) across various cell types, thereby triggering distinct physiological cues.
Bhavya R. Bhaskar+3 more
wiley +1 more source
Assessment of Small Airways Function in Eosinophilic Preserved Ratio Impaired Spirometry. [PDF]
Zhou T+8 more
europepmc +1 more source
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
E. Bel+7 more
semanticscholar +1 more source